Scpharmaceuticals Net Invested Capital vs Accounts Payable Analysis
SCPH Stock | USD 4.75 0.08 1.66% |
Scpharmaceuticals financial indicator trend analysis is much more than just breaking down Scpharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Scpharmaceuticals is a good investment. Please check the relationship between Scpharmaceuticals Net Invested Capital and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.
Net Invested Capital vs Accounts Payable
Net Invested Capital vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Scpharmaceuticals Net Invested Capital account and Accounts Payable. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Scpharmaceuticals' Net Invested Capital and Accounts Payable is -0.51. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Scpharmaceuticals, assuming nothing else is changed. The correlation between historical values of Scpharmaceuticals' Net Invested Capital and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Scpharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Invested Capital i.e., Scpharmaceuticals' Net Invested Capital and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.51 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Accounts Payable
An accounting item on the balance sheet that represents Scpharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Scpharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Scpharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Scpharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.As of now, Scpharmaceuticals' Selling General Administrative is increasing as compared to previous years. The Scpharmaceuticals' current Enterprise Value is estimated to increase to about 246.7 M, while Issuance Of Capital Stock is projected to decrease to under 31.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.6M | 3.3M | 8.1M | 8.5M | Depreciation And Amortization | 364K | 2.6M | 626K | 746.3K |
Scpharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Scpharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Scpharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 77.3M | 109.0M | 79.0M | 124.2M | 94.5M | 90.6M | |
Other Current Liab | 3.7M | 4.8M | 26K | 5.3M | 9.0M | 9.4M | |
Total Current Liabilities | 5.2M | 9.3M | 14.8M | 7.4M | 13.1M | 8.3M | |
Total Stockholder Equity | (129.5M) | (161.7M) | (189.7M) | (226.5M) | 37.2M | 39.1M | |
Other Liab | 58K | 219K | 367K | 7.5M | 8.7M | 9.1M | |
Net Tangible Assets | 51.4M | 82.2M | 63.1M | 72.4M | 83.3M | 54.8M | |
Property Plant And Equipment Net | 1.3M | 908K | 479K | 620K | 1.5M | 1.0M | |
Net Debt | (52.5M) | (85.1M) | (56.6M) | (33.7M) | (6.5M) | (6.9M) | |
Retained Earnings | (129.5M) | (161.7M) | (189.7M) | (226.5M) | (281.3M) | (267.3M) | |
Accounts Payable | 1.1M | 1.7M | 544K | 1.5M | 4.0M | 4.2M | |
Cash | 72.8M | 105.3M | 74.3M | 71.1M | 46.8M | 75.7M | |
Non Current Assets Total | 1.6M | 1.2M | 762K | 887K | 1.5M | 1.2M | |
Non Currrent Assets Other | 148K | 132K | 283K | 267K | 82.0K | 159.4K | |
Other Assets | 330K | 1.1M | 283K | 267K | 1.0 | 0.95 | |
Cash And Short Term Investments | 72.8M | 105.3M | 75.5M | 118.4M | 76.0M | 85.2M | |
Net Receivables | 655K | 479K | 310K | 2.3M | 4.5M | 4.7M | |
Common Stock Shares Outstanding | 18.6M | 24.6M | 27.4M | 28.4M | 38.5M | 22.2M | |
Liabilities And Stockholders Equity | (103.5M) | (134.8M) | (167.1M) | (174.8M) | 94.5M | 99.2M | |
Non Current Liabilities Total | 20.7M | 17.6M | 7.7M | 44.3M | 44.1M | 29.9M | |
Capital Surpluse | 180.8M | 243.8M | 246.2M | 298.9M | 343.8M | 182.1M | |
Inventory | 1.6M | 2.4M | 0.0 | 1.2M | 8.8M | 9.3M | |
Other Current Assets | 94K | 121K | 24K | 1.4M | 3.6M | 3.8M | |
Other Stockholder Equity | 598K | (2K) | (4K) | (35K) | 318.6M | 334.5M | |
Total Liab | 25.9M | 26.9M | 22.6M | 51.8M | 57.3M | 38.2M | |
Property Plant And Equipment Gross | 1.3M | 93K | 649K | 808K | 1.5M | 769.8K | |
Total Current Assets | 75.6M | 107.8M | 78.3M | 123.3M | 92.9M | 89.4M | |
Accumulated Other Comprehensive Income | (600K) | (102K) | 1K | (1K) | 32K | (1.1K) | |
Property Plant Equipment | 1.3M | 908K | 69K | 54K | 48.6K | 46.2K | |
Non Current Liabilities Other | 58K | 219K | 367K | 35K | 177K | 147.7K | |
Short Long Term Debt Total | 20.3M | 20.2M | 17.6M | 37.4M | 40.3M | 24.9M | |
Long Term Debt | 18.9M | 16.9M | 7.4M | 36.8M | 38.8M | 21.2M | |
Long Term Debt Total | 18.9M | 16.9M | 7.4M | 36.8M | 42.3M | 44.4M | |
Capital Lease Obligations | 1.4M | 940K | 476K | 574K | 1.5M | 963.3K | |
Net Invested Capital | 70.3M | 101.4M | 73.6M | 109.2M | 76.0M | 72.5M | |
Net Working Capital | 70.4M | 98.5M | 63.4M | 115.9M | 79.8M | 71.8M | |
Short Term Debt | 407K | 2.9M | 10.3M | 567K | 176K | 167.2K |
Currently Active Assets on Macroaxis
When determining whether Scpharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scpharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scpharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scpharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stocks Directory Find actively traded stocks across global markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.454 | Quarterly Revenue Growth 1.958 | Return On Assets (0.36) | Return On Equity (1.15) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.